Khmelnitskiy Regional Onkology Dispensary ( Site 1705)

Khmelnitskiy, Khmelnytskyi Oblast 29009

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumors

Studies at this site

• Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007) — Completed